bluebird bio Inc.

NASDAQ: BLUE · Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM

bluebird bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
83.81M 29.5M 3.6M 3.66M
Cost of Revenue
89.38M 33.53M 10.08M 38.86M
Gross Profit
-5.57M -4.03M -6.48M -35.2M
Operating Income
-270.46M -244.26M -287.09M -590.91M
Interest Income
8.22M 9.87M 1.03M 879K
Pretax Income
-240.65M -212.04M -266.46M -562.38M
Net Income
-240.72M -211.91M -266.58M -562.64M
Selling & General & Admin
167.87M 165.51M 136.91M 209.97M
Research & Development
94.25M 167.65M 240.76M 319.95M
Other Expenses
n/a -92.93M -102M n/a
Operating Expenses
262.13M 240.23M 275.67M 529.91M
Interest Expense
22.58M 16.35M 6.32M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
351.51M 273.76M 285.75M 568.77M
Income Tax Expense
70K -126K 117K 258K
Shares Outstanding (Basic)
9.69M 71.35M 78.58M 68.91M
Shares Outstanding (Diluted)
9.69M 71.35M 78.58M 68.91M
EPS (Basic)
-24.84 -2.97 -3.39 -8.16
EPS (Diluted)
-24.84 -2.97 -3.39 -8.16
EBITDA
-156.82M -167.16M -215.56M -556.93M
EBIT
-218.07M -195.69M -223.9M -565.11M
Depreciation & Amortization
61.24M 28.52M 5M 5.45M